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Abstract
Background: Behavioural problems are common in nursing home residents with dementia and they often are
burdensome for both residents and nursing staff. In this study, the effectiveness and cost-effectiveness of a new
care programme for managing behavioural problems will be evaluated.
Methods/Design: The care programme is based on Dutch national guidelines. It will consist of four steps:
detection, analysis, treatment and evaluation. A stepped wedge design will be used. A total of 14 dementia special
care units will implement the care programme. The primary outcome is behavioural problems. Secondary
outcomes will include quality of life, prescription rate of antipsychotics, use of physical restraints and workload and
job satisfaction of nursing staff. The effect of the care programme will be estimated using multilevel linear
regression analysis. An economic evaluation from a societal perspective will also be carried out.
Discussion: The care programme is expected to be cost-effective and effective in decreasing behavioural
problems, workload of nursing staff and in increasing quality of life of residents.
Trial registration: The Netherlands National Trial Register (NTR). Trial number: NTR 2141
Background
Many nursing home (NH) residents with dementia suf-
fer from behavioural problems (BPs) like aggression,
apathy and agitation. In a recent Dutch study, BPs were
present in 80 percent of the residents [1]. BPs are asso-
ciated with high costs, diminished quality of life of resi-
dents and a high workload for nurses [1-3].
Antipsychotics and physical restraints are frequently
used to treat BPs [4,5]. However, the use of antipsycho-
tics may have serious negative side effects like extrapyra-
midal symptoms and increased risk of stroke [6-8] and
the use of restraints may result in decreased functional
status and quality of life [9].
Various studies have shown that treatments with less
adverse effects can be used to manage BPs as an alterna-
tive to antipsychotics and physical restraints. For exam-
ple, Cohen-Mansfield and colleagues [10] observed a
positive effect of individualized psychosocial interven-
tions, such as pain treatment, electronic massagers and
individualized music. Furthermore, Livingston et al.
found in their review that staff education and psycholo-
gical and psychosocial treatments were effective [11].
D a v i s o ne ta l .[ 1 2 ]a l s of o u n das i g n i f i c a n td e c r e a s ei n
BPs through the use of psychosocial interventions in
people with dementia in whom individualised pharma-
cological treatment failed to work.
In line with these studies, recent professional demen-
tia guidelines emphasise the use of a systematic multi-
disciplinary approach to treat BPs and stress the
importance of psychosocial interventions and staff train-
ing [13-16]. They also underline that the use of
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Although these guidelines have been developed in colla-
boration with long-term care professionals, implementa-
tion in actual practice is difficult. Unfortunately, this is
also the case in Dutch NHs [17], although the presence
of various care disciplines offers excellent conditions for
a multidisciplinary approach.
A key problem in implementation of guidelines on
BPs seems to be that guidelines do not include a struc-
tured, methodology-based approach how to manage BPs
[18]. For example, an implementation plan on how dif-
ferent disciplines should work together in managing
BPs, is often lacking. Therefore, we developed a care
programme entitled: ‘Grip on challenging behaviour’.
This care-programme, which offers a comprehensible
structure of the care processes, is made practically
applicable and ready to implement. It is based on the
guidelines, fits with daily practice, and describes how
new working methods are related to and can be inte-
grated in the present care process following a step-by-
step plan.
This paper describes the design of the study that eval-
uates the effectiveness and cost-effectiveness of this care
programme for managing BPs in NH residents with
dementia.
Methods/Design
Aim
The aim of this project is to evaluate the effectiveness
and cost-effectiveness of a multidisciplinary care pro-
gramme for managing BPs in NH residents with demen-
tia. The care programme proposes an evidence- and
practice-based standardisation of all consecutive steps in
the management of BP: detection, analysis, treatment
and evaluation (see figure 1). Cooperation between dis-
ciplines is also prearranged and structured.
Intervention
In the first step, the care programme offers a screening
tool to detect symptoms of BPs, next to the usual (daily)
observation and detection of BPs by nurses. When
(symptoms of) BPs are detected, structured forms are
used to analyse the behaviour in the next step of the
care programme. The nursing staff starts the analysis,
after which the elderly care physician and the psycholo-
gist continue analysis when necessary. The outcome of
the analysis is discussed in pre-arranged multidisciplin-
ary team meetings in which the members of the multi-
disciplinary team choose the treatment option (or
options) they consider appropriate, resulting in a written
treatment plan (third step). Psychosocial interventions
are first line treatment options and psychotropics or
physical restraints should only be used when psychoso-
cial interventions have no or not enough effect. In the
fourth step, treatment is evaluated. Standard scales are
used for rating BPs when evaluating the effect of inter-
ventions. When treatment outcomes are unsatisfactory,
alternative treatment options may be chosen and/or a
new analysis will be done.
Design
The care programme will be implemented using a stepped
wedge design (Table 1). A stepped wedge design is a type
of cross-over design in which different clusters (in this
case dementia special care units (SCUs)) cross-over from
control-condition to intervention over time [19]. In this
Figure 1 Components of the care programme ‘Grip on challenging behaviour’.
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over five groups. Four groups consist of three dementia
SCUs from three different NHs, one group consists of two
dementia SCUs from two different NHs.
Six measurement cycles will take place: one measure-
ment cycle every four months during a period of twenty
months. The first measurement cycle is a baseline mea-
surement on all participating units. After each measure-
ment cycle, except the last one, a new group will start
the intervention. The moment after which measurement
cycle a group of units will start is randomised.
A process analysis will be carried out during the study
on the actual provision and use of the components of
the care programme and on barriers and facilitators
of implementation. The process analysis will consist of
qualitative interviews with key persons within the NHs.
Sampling
We calculated the sample-size using the following
assumptions: On average, a dementia SCU houses 20
residents. Based on a previous study, we expect that 5%
of the residents’ (legal) representatives will not give
informed consent [1]. We expect no further attrition,
because newly admitted residents will replace discharged
and deceased residents during the study. For the pri-
mary outcome, we assume that our care programme
leads to a 10 point decrease of BPs, measured with the
Cohen-Mansfield Agitation Inventory (CMAI) [20].
Based on a Dutch study in NH patients [21], we assume
a mean Intra Class Correlation Coefficient of 0.1. for
clustering of BPs within a unit and a mean score of 47.7
(SD = 16.6) on the CMAI in NH patients with dementia.
Based on these assumptions and a significance level
(alpha) of 0.05 and a power (beta) of 0.80, 14 dementia
SCUs with 6 measurements are needed in a stepped
wedge design.
The participating dementia SCUs will be recruited
from NHs that collaborate with the VU University Med-
ical Center (Amsterdam) and the Radboud University
Nijmegen, Medical Center. The dementia SCUs partici-
pating in this study are not allowed to exchange staff
between SCUs, in order to avoid carry-over effects, and
thus dilution of the effect.
Ethical approval
The study protocol was approved by the Medical Ethics
Review Committee of the VU University Medical Cen-
ter. All data will be anonymized and (legal) representa-
tives will have the opportunity to object to the use of
data from their relative.
Measurements
Patient characteristics
Sociodemographic variables (e.g., age, gender, and length
of stay) and the use of physical restraints will be col-
lected from resident charts.
Severity of dementia will be determined by elderly care
physicians, using the Global Deterioration scale (GDS)
[22]. The GDS is a validated seven-point scale that
describes seven different stages of dementia ranging
from “subjectively and objectively normal” to “severe
dementia”.
Data about psychotropic drug use (including antipsy-
chotics) will be derived from the NH pharmacists’ elec-
tronic registration system and will be classified
according to the Anatomical Therapeutic Chemical
(ATC) classification system [23].
Behavioural problems will be measured using the
Cohen-Mansfield Agitation Inventory (CMAI) and the
Neuropsychiatric Inventory - Nursing Home version
(NPI-NH). To our knowledge, the CMAI is the only
instrument specifically addressing agitation and aggres-
sion, with an adequate validity and reliability for the
Dutch version [24,25]. The CMAI will be used in primary
effect analyses that focus on agitation and aggression,
which are the most prevalent and most stressing BPs [4].
The NPI-NH is a version of the Neuropsychiatric
Inventory [26] that is adjusted to the NH setting. The
questionnaire contains twelve items which each measure
the frequency and severity of a neuropsychiatric symp-
tom. It was developed for rating by professional care-
givers within institutions [27,28]. The Dutch version
proved to be valid and reliable [29].
Quality of life of residents will be measured with the
Qualidem, a Dutch dementia specific observational
quality of life instrument. With this instrument, nursing
staff can rate quality of life of the resident over the last
week. The Qualidem has nine subscales: Care relation-
ship, Positive affect, Negative effect, Restless tense beha-
viour, Positive self image, Social relations, Social
isolation, Feeling at home and Having something to do.
The Qualidem was proven to be valid and reliable,
although some items are not applicable to patients with
severe dementia (GDS state 7) [30,31].
Nursing staff characteristics
Characteristics of the nursing staff (e.g. gender, working
experience) are collected through the use of a
questionnaire.
Table 1 Flow chart of the stepped wedge design
(0 = control condition; 1 = intervention)
T0 T1 T2 T3 T4 T5
Group 1 011111
Group 2 001111
Group 3 000111
Group 4 000011
Group 5 000001
The groups will start with the care programme on six different point in time
(T0 through T5).
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Dutch version of the Maslach Burnout Inventory [32],
the Utrechtse Burnout Scale-C [33]. The UBOS mea-
sures three components of workload and burnout: emo-
tional exhaustion, depersonalisation and decreased
personal accomplishment.
Job satisfaction will be measured using two subscales
of the Leiden quality of work questionnaire [34]. The
two subscales measure job satisfaction and work and
time pressure. The attitude of nursing staff to dementia
care will be measured using the approaches to dementia
questionnaire (ADQ) [35].
Special dementia care unit characteristics
The Special Care Unit Environmental Quality Scale
(SCUEQS) is used for the characteristics of the physical
environment. The SCUEQS is a summary scale com-
prised of items from a larger observational instrument
(the TESS-NH) which gathers data on the physical
environment of a long-term care facility. The eighteen
items measure maintenance, cleanliness, safety, lighting,
physical appearance/homelikeness, orientation/cuing and
noise [36]. In addition information about nursing staff-
resident ratio and educational level of nursing staff will
be gathered.
Data analysis
The CMAI-score and the NPI-NH score will be used as
a primary outcome. Age, gender, length of stay, demen-
tia severity, prescription of antipsychotics and of other
psychotropics will be used as covariates. For the primary
and secondary outcome analyses, multilevel linear
regression and multilevel logistic regression analyses will
be used. These analyses will calculate effects on neurop-
sychiatric symptoms, quality of life (Qualidem), prescrip-
tion rate of antipsychotics, workload and job satisfaction
of nursing staff and use of physical restraints.
Economic evaluation
The economic evaluation will be conducted from a soci-
etal perspective. We will measure and value all relevant
costs, such as costs of the structured care programme,
prescription of antipsychotics and hospital admission.
Data will be collected using NH registries. Standardised
case report forms will be used to measure the time
invested by NH staff (e.g. recreational therapist, nursing
staff, psychologist, elderly care physician) in both the
intervention and the usual care condition. Absence rate
of nurses will be retrieved from the participating NHs.
The EuroQol (EQ-5D) proxy version [37] will be used
to measure quality adjusted life years (QALYS). Missing
data on cost and outcomes will be imputed using multi-
ple imputation according to the MICE algorithm [38].
A cost-effectiveness analysis will be conducted com-
paring the difference in total mean costs to the
difference in effects on BPs; a cost-utility analysis will
estimate the incremental costs per QALY. Bootstrapping
will be used to estimate uncertainty of the incremental
cost-effectiveness ratios (ICERs), which will be presented
on cost-effectiveness planes. Cost-effectiveness accept-
ability curves and net monetary benefits will also be cal-
culated [39]. Sensitivity analysis will include the most
important cost-drivers.
Discussion
The aim of this study is to measure the effectiveness
and cost-effectiveness of an evidence- and practice-
based care programme for managing BPs in NH resi-
dents with dementia. Primary outcome is the effect on
prevalence of BP. Secondary outcomes are the effect on
quality of life, use of antipsychotics and physical
restraints and on workload and job satisfaction of nur-
sing staff. Additionally, an economic evaluation will be
carried out.
We assume that implementation of the care pro-
gramme will result in a decrease of BPs and, subse-
quently, in an increase of the quality of life of the
residents. We also expect lower costs that will most
likely be the result of a decrease of behavioural-problem
related extra care, a decrease of medication, fewer
admissions to hospital and also by a lower absence rate
of nursing staff. Implementation is also expected to
result in a lower workload and higher job satisfaction
among nursing staff.
The chosen design to implement and evaluate the care
programme is suitable for our purposes. Not only does
the stepped wedge design increase the power of the
s t u d yb ye n a b l i n gb e t w e e n -groups and within-group
analyses, it also ensures that implementation of the care
programme occurs in all participating care units, which
likely increases motivation for participating in the study
[40]. Except for the EQ5D, which is used to calculate
QALYs, the chosen outcome parameters are all com-
monly used in the field of nursing home medicine and
are also suitable for the population of severely demented
patients [22,24,27,31].
The study has some limitations that should be men-
tioned. One limitation of the study is that, although data
collection will be done by research assistants who are
blinded for the trial condition, the NH staff will be
aware of receiving the intervention, which may cause
b i a s .T ol i m i tt h i sb i a s ,n u r s i n gs t a f fw i l ln o tb e
informed about the scores on the outcome measures.
Another limitation is that we use proxy measures only,
which may not be as reliable as patient measures [41].
However, in advancing stages of dementia, cognition
and communication decrease, which makes the use of
proxy measures inevitable [41]. Nevertheless, the
described care programme for managing BP in NH
Zwijsen et al. BMC Health Services Research 2011, 11:41
http://www.biomedcentral.com/1472-6963/11/41
Page 4 of 6residents with dementia and the chosen stepped wedge
design seem very appropriate for our research goals.
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